Cargando…
Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma
The resistance of apoptosis in cancer cells is pivotal for their survival and is typically ruled by mutations or dysregulation of core apoptotic cascade. Mantle cell lymphoma (MCL) is a non-Hodgkin's B-cell malignancy expressing higher anti-apoptotic proteins providing survival advantage. B-PAC...
Autores principales: | Sarkar, Aloke, Balakrishnan, Kumudha, Chen, Jefferson, Patel, Viralkumar, Neelapu, Sattva S., McMurray, John S., Gandhi, Varsha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823120/ https://www.ncbi.nlm.nih.gov/pubmed/26658105 http://dx.doi.org/10.18632/oncotarget.6505 |
Ejemplares similares
-
Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma
por: Sarkar, Aloke, et al.
Publicado: (2020) -
Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers
por: Schlein, Lisa J., et al.
Publicado: (2019) -
Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1(+) T-cell subsets
por: Chu, Fuliang, et al.
Publicado: (2014) -
Targeting procaspase-3 with WF-208, a novel PAC-1 derivative, causes selective cancer cell apoptosis
por: Wang, Fangyang, et al.
Publicado: (2015) -
Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012)